Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
|Articles|December 2, 2014
- Pharmaceutical Technology-12-02-2014
- Volume 38
- Issue 12
VIDEOJET Thermal Ink Printer Offers Increased Resolution
VIDEOJET’s thermal ink jet printer, the Videojet 8610, is designed for high-resolution coding with MEK-based fluids on non-porous packaging, including films, foils, plastics, and coated stocks.
VIDEOJET’s thermal ink jet printer, the Videojet 8610, is designed for high-resolution coding with MEK-based fluids on non-porous packaging, including films, foils, plastics, and coated stocks.
The printer features three components: a controller with user interface, an industrial printhead featuring a Cartridge Readiness System, and a disposable ink-jet cartridge. It has wear-resistant parts and no calibration or tuning requirements.
Each cartridge change provides a new print array. Code Assurance assists operators in getting the correct code on the product, the company reports.
VIDEOJET
Articles in this issue
almost 12 years ago
Sartorius Bioreactor and Microbial Fermenter Increases Efficiencyalmost 12 years ago
Ross Planetary Mixers Increase Mixing Optionsalmost 12 years ago
The Bio/Pharma Working Lifealmost 12 years ago
FDA Realigns Drug Inspection and Manufacturing Oversightalmost 12 years ago
Fitzpatrick Roll Compaction Series Improves Accuracyalmost 12 years ago
Drug Scandals Impact Industry in Japanalmost 12 years ago
Securing the Single-Use Supply Chainalmost 12 years ago
Improving Job Market Creates Opportunity for Changealmost 12 years ago
FDA Approves Novel Treatments in 2014almost 12 years ago
Novel Technologies Win CPhI Pharma AwardsRelated to this article
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Terry Katz, CEO and cofounder of ForgeStop Technology Corporation, explains the company’s CPHI Award-winning connected product technology and how it helps to combat drug counterfeiting.
FDA approved pimicotinib for TGCT based on a 56% response rate; its Project Orbis review signals tighter global launch planning for manufacturers.
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
Our Biggest Takeaways From AAPS PharmSci 360
3
France Remains One of Europe’s Leading Biotech Funding Hubs
4
$1.15B AI-Guided Macrocycle Discovery Lands at argenx
5